Clinical Trials Sponsored by Bellus Health Inc

Total 3334 results

Bellus Health Inc

Completed

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (SOOTHE)

Refractory Chronic Cough

United States, Germany, Canada, Czechia, Hungary, Poland, United Kingdom
Bellus Health Inc

Completed

A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis (BLUEPRINT)

Atopic Dermatitis | Chronic Pruritus

United States, Canada
Bellus Health Inc

Completed

BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect

Cough

Canada
Bellus Health Inc

Unknown

Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Bellus Health Inc

Completed

Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]-BLU-5937

Healthy

United Kingdom
Bellus Health Inc

Terminated

A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough (RELIEF)

Chronic Refractory Cough

United States, United Kingdom
Bellus Health Inc

Completed

A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes

Diabetes Mellitus, Type 2 | Metabolic Syndrome X

Canada
Bellus Health Inc

Unknown

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Alzheimer's Disease

Poland, France, Spain, Switzerland, Netherlands, Italy, Germany, Sweden, United Kingdom, Belgium
Bellus Health Inc

Unknown

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Canada, United States
Bellus Health Inc. - a GSK company

Completed

Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

Healthy

Canada
Bellus Health Inc. - a GSK company

Recruiting

A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age

Cough

United States
Bellus Health Inc. - a GSK company

Recruiting

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1)

Refractory Chronic Cough

United States, Canada, Israel, Spain, Belgium, United Kingdom, South Africa, Argentina, Netherlands, Hungary, Colombia, Turkey, Poland, France, India
Bellus Health Inc. - a GSK company

Recruiting

Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation

Healthy | Cough

United Kingdom
Bellus Health Inc. - a GSK company

Completed

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

Healthy

Canada
Bellus Health Inc. - a GSK company

Completed

Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects

Healthy

United Kingdom
Bellus Health Inc. - a GSK company

Recruiting

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

Refractory Chronic Cough

Korea, Republic of, United States, Taiwan, Australia, New Zealand, Czechia, United Kingdom, Germany, Slovakia, India
Bellus Health Inc
FDA Office of Orphan Products Development

Completed

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Gastrointestinal Diseases | Kidney Diseases | Rheumatoid Arthritis | Nephrotic Syndrome | Secondary (AA) Amyloidosis | Familial Mediterranean Syndrome

United States, Israel, Finland, France, Italy, Lithuania, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom
Helius Medical Inc

Recruiting

PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study

Chronic Stroke Survivors

United States
Helius Medical Inc

Recruiting

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) (PoNSTEP)

Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)

United States
Helius Medical Inc

Completed

Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)

Traumatic Brain Injury | Chronic Balance Disorder

United States, Canada
Bellus Health Inc
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

Stroke | Neurologic Diseases, General

United States
Helius Medical Inc
Oregon Health and Science University

Unknown

PoNS Clinical Experience Program (TBI)

Mild to Moderate Traumatic Brain Injury

United States
KLSMC Stem Cells, Inc.

Completed

Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee

Articular Cartilage Disorder of Knee | Articular Cartilage; Degeneration

United States, Malaysia
Personalized Stem Cells, Inc.

Unknown

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Knee Osteoarthritis

United States
Helius Medical Inc
McGill University

Completed

Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis

Multiple Sclerosis
Helius Medical Inc
Ohio State University

Unknown

PoNS Clinical Experience Program (TBI)

Mild to Moderate Traumatic Brain Injury

United States
Helius Medical Inc
Kessler Institute for Rehabilitation

Unknown

PoNS Clinical Experience Program (TBI)

Mild to Moderate Traumatic Brain Injury

United States
Helius Medical Inc
Baylor Institute for Rehabilitation

Unknown

PoNS Clinical Experience Program (TBI)

Mild to Moderate Traumatic Brain Injury

United States
Ministry of Public Health, Republic of Belarus

Completed

Safety of Autologous MSC Infusion to Treat Epilepsy (AMSCDRSE)

Epilepsy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Recruiting

Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System

Fistula | Crohn Disease | Adipose Tissue

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity

Obesity

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing

Dysplasia in IBD

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Interactions Between Diet, Intestinal Microbiota and Metabolomics

Nutrition Disorders

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Glycemic Index of Traditional Egg Pasta

Healthy Subjects | Glycemic Response | Insulinemic Response

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Diet and Physical Activity on NAFLD and Erytrocyte Membrane Lipid Profile.

NAFLD

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of Physical Activity on NAFLD

NAFLD
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of Low-Glycemic Index Mediterranean Diet on AGEs (Nutri_AGEs)

Obesity | Cardiovascular Disease | Insulin Resistance | Type 2 Diabetes

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Lactobacillus Reuteri DSM 17938 in Functional Constipation (LRFC)

Functional Constipation

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease (Nutriepa)

NAFLD

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant (DIETSINIBS)

Irritable Bowel Syndrome

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Active, not recruiting

Grape Polyphenols and Metabolic Syndrome (PolyGrape)

Metabolic Syndrome, Protection Against

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Glycemic Index of Various Types of Pasta in Healthy Volunteers

Glycemic Index
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Performance of Six Equations for Estimating Resting Energy Expenditure in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

25-Hydroxyvitamin D Levels Are Negatively Associated With Platelets Number in a Cohort of Overweight and Obese Subjects

Obesity

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Unknown

Characteristics of Subjects With Overweight or Obesity at the Onset of Hypertension

Hypertension | Obesity

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Effect of a Low Glycemic Index on Metabolic Syndrome

Metabolic Syndrome X

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Gastric Activity and Gastrointestinal Peptides in Patients With Functional Dyspepsia (DYSMOT-RIII)

Dyspepsia

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome (PPCD)

Irritable Bowel Syndrome | Celiac Disease

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Recruiting

Exercise, Irritable Bowel Syndrome and Fibromyalgia (AF-IBS-FM)

Irritable Bowel Syndrome | Fibromyalgia

Italy
Azienda Ospedaliera Specializzata in Gastroenterologia...

Recruiting

Exercise and Irritable Bowel Syndrome (IBS) (AF_IBS)

Irritable Bowel Syndrome (IBS)

Italy

Clinical Trials Sponsored by Bellus Health Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations